Chemomab Therapeutics Ltd. (CMMB)

Price & Market Data

Price: $2.02

Daily Change: +$0.201 / 9.96%

Daily Range: $1.67 - $2.09

Market Cap: $14,544,763

Daily Volume: 90,466

Performance Metrics

1 Week: 11.05%

1 Month: 15.76%

3 Months: 18.63%

6 Months: -23.29%

1 Year: -64.89%

YTD: 15.06%

About Chemomab Therapeutics Ltd. (CMMB)

A complete market overview for Chemomab Therapeutics Ltd. (CMMB). The stock is at 2.02, with a daily change of +$0.201 / 9.96%. Market cap: 14,544,763. Delve into its YTD and 3-month performance.

Company Details

Employees: 12

Sector: Health technology

Industry: Biotechnology

Country: Israel

Details

Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating primary sclerosing cholangitis, as well as in phase 2 clinical trial to treat systemic sclerosis. The company was founded in 2011 and is based in Tel Aviv-Yafo, Israel.

Selected stocks

Frontier Group Holdings, Inc. (ULCC)

Biomea Fusion, Inc. (BMEA)

ZK International Group Co., Ltd (ZKIN)

Inotiv, Inc. (NOTV)

Nixxy, Inc. (NIXX)